BGNE

Q: What is the price of BeiGene (BGNE) today?

The price of BeiGene (BGNE) today is $ 0.00, with return of 0% compared to the last year. The price of BeiGene (BGNE) started the year trading around $ 184.71 and today it is at $ 0.00. Follow the real-time price chart, the historical price of BeiGene (BGNE) and international markets.

Q: When does BeiGene (BGNE) pay dividends?

BeiGene (BGNE) did not distribute dividends in the last year.

Q: Is BeiGene (BGNE) worth it?

Currently, BeiGene (BGNE) is priced at $ 0.00, with a P/E of -22.41%, representando um desvio de -5,253% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy BeiGene (BGNE) stock?

Investing in stocks of BeiGene (BGNE) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of BeiGene (BGNE) yield today?

The yield of BeiGene (BGNE) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of BeiGene (BGNE) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

BeiGene Ltd.

Price

$ -

return (12m)

0.00%

p/e

-22.41

p/bv

5.61

DIVIDEND YIELD

0.00%

price BGNE

BGNE

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of BGNE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BGNE

review the fundamentals of BeiGene shares

P/E

-22.41

Sector: -3.40 Industry: -3.40

P/SALES RATIO (PSR)

5.81

Sector: -3.36 Industry: -3.36

P/BV

5.61

Sector: 1.98 Industry: 1.98

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-14.76%

Sector: -62.78% Industry: -62.78%

ROE

-25.04%

Sector: -68.26% Industry: -68.26%

ROIC

-19.43%

Sector: -1,140.39% Industry: -1,140.39%

NET MARGIN

-25.94%

Sector: -41.80% Industry: -41.80%

GROSS MARGIN

83.74%

Sector: 39.33% Industry: 39.33%

OPERATING MARGIN

-26.31%

Sector: -41.58% Industry: -41.58%

P/EBITDA

-26.51

Sector: -3.48 Industry: -3.48

P/EBIT

-22.10

Sector: -3.60 Industry: -3.60

P/ASSET

3.31

Sector: 1.42 Industry: 1.42

BVPS

32.42

Sector: 1.79 Industry: 1.79

EPS

-8.12

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.59

Sector: 0.42 Industry: 0.42

CAGR REVENUE 5 YEARS

60.76%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-11.63%

Sector: - Industry: -

Fundamentals BGNE

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.42	0.00	0.00%	2.51%	$ 487.73 B	27.26%
PFE	14.23	1.50	10.56%	6.95%	$ 139.89 B	15.65%
ABBV	102.44	-2,793.44	-2,726.81%	2.97%	$ 385.49 B	6.45%
NVO	13.73	7.92	57.70%	3.54%	$ 211.67 B	32.78%
MRK	12.83	0.00	0.00%	3.31%	$ 244.20 B	29.63%
AZN	30.03	6.14	20.45%	1.72%	$ 282.28 B	16.17%
BMY	15.59	5.06	32.47%	5.36%	$ 94.17 B	12.57%
GILD	19.41	7.34	37.80%	2.48%	$ 157.41 B	27.88%
ZTS	20.40	10.02	49.11%	1.58%	$ 54.07 B	28.21%
HALO	13.82	16.33	118.17%	0.00%	$ 8.23 B	47.91%
REGN	17.17	2.54	14.79%	0.35%	$ 78.61 B	32.13%
AMGN	25.92	18.88	72.82%	2.78%	$ 181.60 B	19.47%
VRTX	29.73	6.31	21.22%	0.00%	$ 109.25 B	31.35%
MCK	26.63	-185.79	-697.75%	0.34%	$ 107.39 B	1.04%
ADMA	19.60	9.52	48.57%	0.00%	$ 4.11 B	42.87%
CAH	31.26	-18.26	-58.40%	0.97%	$ 49.86 B	0.68%
BIIB	16.02	1.42	8.83%	0.00%	$ 25.77 B	15.98%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

BGNE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY BeiGene

BeiGene Ltd.

Average user rating I10

4.0 (4 people)

United States

15 years

Founded: 2010

2016

Time since IPO - 9 years

5.300

Employees

The Company BeiGene Ltd. (United States), is listed on Nasdaq with a market cap of $ 19.28 Billions, having an equity of $ 3.44 Billions.

With a total of 5.300 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 3.32 Billions, which generated a loss in the amount of $ -860.46 Millions.

As for its main indicators, the Company has a P/E ratio of -22.41, a P/BV ratio of 5.61 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker BGNE.

Market cap

$ 19.28 Billions

Equity

$ 3.44 Billions

US$ 3,436,070,000.00

Assets

$ 5.83 Billions

US$ 5,830,860,000.00

Total Shares Outstanding

106.00 Millions

106,000,000

Average Daily Trading Volume

$ 370.98 Thousand

US$ 370,981.82

Sector

Health Care

Industry

Biotechnology

BGNE

BGNE revenue and profits

Financial Results BGNE

DRAG THE FRAME TO SEE MORE DATA

BGNE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 889.28 43,05% (12M)

P/E

26.63

0.34%

ROE

-697.75%

P/BV

-185.79

CAH - Cardinal Health

$ 213.73 77,50% (12M)

P/E

31.26

0.97%

ROE

-58.40%

P/BV

-18.26

JNJ - Johnson & Johnson

$ 206.67 39,00% (12M)

P/E

19.42

2.51%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 105.66 8,77% (12M)

P/E

12.83

3.31%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.72 8,48% (12M)

P/E

14.23

6.95%

ROE

10.56%

P/BV

1.50

ABBV - AbbVie

$ 231.80 32,43% (12M)

P/E

102.44

2.97%

ROE

-2,726.81%

P/BV

-2,793.44

AZN - AstraZeneca

$ 93.24 43,50% (12M)

P/E

30.03

1.72%

ROE

20.45%

P/BV

6.14

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 889.28 43,05% (12 M)

P/L

26.63

0.34%

ROE

-697.75%

P/VP

-185.79

CAH - Cardinal Health

$ 213.73 77,50% (12 M)

P/L

31.26

0.97%

ROE

-58.40%

P/VP

-18.26

JNJ - Johnson & Johnson

$ 206.67 39,00% (12 M)

P/L

19.42

2.51%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 105.66 8,77% (12 M)

P/L

12.83

3.31%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.72 8,48% (12 M)

P/L

14.23

6.95%

ROE

10.56%

P/VP

1.50

ABBV - AbbVie

$ 231.80 32,43% (12 M)

P/L

102.44

2.97%

ROE

-2,726.81%

P/VP

-2,793.44

AZN - AstraZeneca

$ 93.24 43,50% (12 M)

P/L

30.03

1.72%

ROE

20.45%

P/VP

6.14

Frequently Asked Questions

What is the price of BeiGene (BGNE) today?

The price of BeiGene (BGNE) today is $ 0.00, with return of 0% compared to the last year. The price of BeiGene (BGNE) started the year trading around $ 184.71 and today it is at $ 0.00. Follow the real-time price chart, the historical price of BeiGene (BGNE) and international markets.

When does BeiGene (BGNE) pay dividends?

BeiGene (BGNE) did not distribute dividends in the last year.

Is BeiGene (BGNE) worth it?

Currently, BeiGene (BGNE) is priced at $ 0.00, with a P/E of -22.41%, representando um desvio de -5,253% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy BeiGene (BGNE) stock?

Investing in stocks of BeiGene (BGNE) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of BeiGene (BGNE) yield today?

The yield of BeiGene (BGNE) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of BeiGene (BGNE) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.00
In 5 years: $ 0.00
In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

BGNE

BeiGene Ltd.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of BGNE

review the fundamentals of BeiGene shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY BeiGene

BeiGene Ltd.

United States

15 years

2016

5.300

PROFIT X PRICE BGNE

Financial Results BGNE

BGNE cash flow

asset growth - BGNE

BGNE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions